{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:02:46Z","timestamp":1771956166426,"version":"3.50.1"},"reference-count":119,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T00:00:00Z","timestamp":1514419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Considerable progress has been made recently in understanding the complex pathogenesis and treatment of spondyloarthropathies (SpA). Currently, along with traditional disease modifying anti-rheumatic drugs (DMARDs), TNF-\u03b1, IL-12\/23 and IL-17 are available for treatment of such diseases as ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Although they adequately control inflammatory symptoms, they do not affect the abnormal bone formation processes associated with SpA. However, the traditional therapeutic approach does not cover the regenerative treatment of damaged tissues. In this regards, stem cells may offer a promising, safe and effective therapeutic option. The aim of this paper is to present the role of mesenchymal stromal cells (MSC) in pathogenesis of SpA and to highlight the opportunities for using stem cells in regenerative processes and in the treatment of inflammatory changes in articular structures.<\/jats:p>","DOI":"10.3390\/ijms19010080","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T11:24:33Z","timestamp":1514460273000},"page":"80","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Role of Stem Cells in Pathophysiology and Therapy of Spondyloarthropathies\u2014New Therapeutic Possibilities?"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7857-347X","authenticated-orcid":false,"given":"Magdalena","family":"Krajewska-W\u0142odarczyk","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Municipal Hospital in Olsztyn, 10-900 Olsztyn, Poland"},{"name":"Department of Pathophysiology, Faculty of Medicine, University of Warmia and Mazury, 10-900 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8660-4889","authenticated-orcid":false,"given":"Agnieszka","family":"Owczarczyk-Saczonek","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, Faculty of Medicine, University of Warmia and Mazury, 10-900 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Placek","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, Faculty of Medicine, University of Warmia and Mazury, 10-900 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0544-5653","authenticated-orcid":false,"given":"Adam","family":"Osowski","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Faculty of Medicine, University of Warmia and Mazury, 10-900 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Engelgardt","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Faculty of Medicine, University of Warmia and Mazury, 10-900 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-3644","authenticated-orcid":false,"given":"Joanna","family":"Wojtkiewicz","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Faculty of Medicine, University of Warmia and Mazury, 10-900 Olsztyn, Poland"},{"name":"Laboratory for Regenerative Medicine, Faculty of Medicine, University of Warmia and Mazury, 10-900 Olsztyn, Poland"},{"name":"Foundation for Nerve Cell Regeneration, University of Warmia and Mazury in Olsztyn, 10-900 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/BOR.0b013e32833ac5cc","article-title":"New approaches to diagnosis and classification of axial and peripheral spondyloarthritis","volume":"22","author":"Rutwaleit","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/annrheumdis-2014-205322","article-title":"Efficacy of TNF-\u03b1 blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: A meta-analysis","volume":"74","author":"Callhoff","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/annrheumdis-2013-204248","article-title":"Ustekinumab for the treatment of patients with active ankylosing spondylitis: Results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)","volume":"73","author":"Poddubnyy","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: A randomised, double-blind, placebocontrolled trial","volume":"382","author":"Baeten","year":"2013","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4252\/wjsc.v6.i5.526","article-title":"Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy","volume":"6","author":"Glenn","year":"2014","journal-title":"World J. Stem Cells"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"International Society for Cellular Therapy. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.1073\/pnas.141221698","article-title":"Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells","volume":"98","author":"Colter","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1089\/scd.2012.0263","article-title":"Concerted regulation of CD34 and CD105 accompanies mesenchymal stromal cell derivation from human adventitial stromal cell","volume":"22","author":"Braun","year":"2013","journal-title":"Stem Cells Dev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/14653240802217011","article-title":"Heterogeneity of mesenchymal stromal cell preparations","volume":"10","author":"Ho","year":"2008","journal-title":"Cytotherapy"},{"key":"ref_10","first-page":"265","article-title":"Stem cells\u2014Biological update and cell therapy progress","volume":"88","author":"Girlovanu","year":"2015","journal-title":"Clujul Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/jbm.a.36089","article-title":"Bone marrow-derived stem\/stromal cells and adipose tissue-derived stem\/stromal cells: Their comparative efficacies and synergistic effects","volume":"105","author":"Im","year":"2017","journal-title":"J. Biomed. Mater. Res. A"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.stem.2012.05.015","article-title":"Mesenchymal stromal cells: New directions","volume":"10","author":"Keating","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-immunol-032712-095919","article-title":"Mesenchymal stem cell: Keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine","volume":"31","author":"Frenette","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2014.02.013","article-title":"Mesenchymal stem\/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis","volume":"143","author":"Bronckaers","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/stem.1400","article-title":"Concise review: Two negative feedback loops place mesenchymal stem\/stromal cells at the center of early regulators of inflammation","volume":"31","author":"Prockop","year":"2013","journal-title":"Stem Cells"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fimmu.2012.00182","article-title":"Toll-like receptors as modulators of mesenchymal stem cells","volume":"3","author":"Delarosa","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.humimm.2009.12.005","article-title":"Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells","volume":"71","author":"Raicevic","year":"2010","journal-title":"Hum. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mo, I.F., Yip, K.H., Chan, W.K., Law, H.K., Lau, Y.L., and Chan, G.C. (2008). Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors. BMC Cell Biol., 9.","DOI":"10.1186\/1471-2121-9-52"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Waterman, R.S., Tomchuck, S.L., Henkle, S.L., and Betancourt, A.M. (2010). A new mesenchymal stem cell (MSC) paradigm: Polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010088"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00384-006-0133-6","article-title":"Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa of ulcerative colitis patients","volume":"22","author":"Heuschen","year":"2007","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/art.21155","article-title":"Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy","volume":"52","author":"Vandooren","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2249.2007.03396.x","article-title":"Increased expression of Toll-like receptor 4 in peripheral blood leucocytes and serum levels of some cytokines in patients with ankylosing spondylitis","volume":"149","author":"Yang","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_24","first-page":"374","article-title":"Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: A pathogenic role for innate immunity","volume":"34","author":"Candia","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/rheumatology\/keq362","article-title":"Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis","volume":"50","author":"Myles","year":"2011","journal-title":"Rheumatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1189\/jlb.0410207","article-title":"Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge","volume":"88","author":"Brandau","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/path.4133","article-title":"Macrophage plasticity and polarization in tissue repair and remodelling","volume":"229","author":"Mantovani","year":"2013","journal-title":"J. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/stem.651","article-title":"Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils","volume":"29","author":"Cassatella","year":"2011","journal-title":"Stem Cells"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/cdd.2012.26","article-title":"Mesenchymal stem cells: A double-edged sword in regulating immune responses","volume":"19","author":"Li","year":"2012","journal-title":"Cell Death Differ."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.immuni.2011.02.016","article-title":"Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands","volume":"34","author":"Shi","year":"2011","journal-title":"Immunity"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Chen, L., Tredget, E.E., Wu, P.Y., and Wu, Y. (2008). Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001886"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s12015-013-9455-2","article-title":"Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages","volume":"9","author":"Abumaree","year":"2013","journal-title":"Stem Cell Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1038\/emm.2013.135","article-title":"Mesenchymal stem cells reciprocally regulate the M1\/M2 balance in mouse bone marrow-derived macrophages","volume":"46","author":"Cho","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00395-011-0221-9","article-title":"Mesenchymal stromal cells mediate a switch to alternatively activated monocytes\/macrophages after acute myocardial infarction","volume":"106","author":"Dayan","year":"2011","journal-title":"Basic Res. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2047-1440-1-12","article-title":"Mesenchymal stem cell-educated macrophages","volume":"1","author":"Eggenhofer","year":"2012","journal-title":"Transp. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"Nemeth","year":"2009","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zhao, J., Yuan, W., Tao, C., Sun, P., Yang, Z., and Xu, W. (2017). M2 polarization of monocytes in ankylosing spondylitis and relationship with inflammation and structural damage. APMIS.","DOI":"10.1111\/apm.12757"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/rheumatology\/ket323","article-title":"Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis","volume":"53","author":"Ciccia","year":"2014","journal-title":"Rheumatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/ard.2005.050963","article-title":"Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: Implications for treatment","volume":"65","author":"Smeets","year":"2006","journal-title":"Ann. Rheum Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/kes364","article-title":"The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis","volume":"52","author":"Kang","year":"2013","journal-title":"Rheumatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/stem.1040","article-title":"Induction of Osteogenesis in mesenchymal stem cells by activated monocytes\/macrophages depends on oncostatin M signaling","volume":"30","author":"Guihard","year":"2012","journal-title":"Stem Cells"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.4049\/jimmunol.1000041","article-title":"Human intestinal lamina propria CD1c+ dendritic cells display an activated phenotype at steady state and produce IL-23 in response to TLR7\/8 stimulation","volume":"184","author":"Dillon","year":"2010","journal-title":"J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.24763","article-title":"HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats","volume":"60","author":"DeLay","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1002\/art.34561","article-title":"Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondyloarthritis","volume":"64","author":"Utriainen","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t(+)CD3(+)CD4(-)CD8(-) entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.177.4.2080","article-title":"Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells","volume":"177","author":"Nauta","year":"2006","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/154732804323099190","article-title":"Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells","volume":"13","author":"Zhang","year":"2004","journal-title":"Stem Cells Dev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","article-title":"MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: Central role of MSC-derived prostaglandin E2","volume":"113","author":"Spaggiari","year":"2009","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"17384","DOI":"10.1073\/pnas.1103650108","article-title":"Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells","volume":"108","author":"Chiesa","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00125-015-3808-0","article-title":"Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients","volume":"59","author":"Favaro","year":"2016","journal-title":"Diabetologia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","article-title":"Analysis of IL-17+ cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response","volume":"13","author":"Appel","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1042\/CBI20110070","article-title":"Human mesenchymal stem cells protect neutrophils from serum-deprived cell death","volume":"35","author":"Maqbool","year":"2011","journal-title":"Cell Biol. Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1634\/stemcells.2007-0416","article-title":"Human mesenchymal stem cells inhibit neutrophil apoptosis: A model for neutrophil preservation in the bone marrow niche","volume":"26","author":"Raffaghello","year":"2008","journal-title":"Stem Cells"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/cmi.2010.42","article-title":"Contribution of functional KIR3DL1 to ankylosing spondylitis","volume":"7","author":"Zvyagin","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","article-title":"Interactions between human mesenchymal stem cells and natural killer cells","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system","volume":"12","author":"Mougiakakos","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1634\/stemcells.2008-0687","article-title":"Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells","volume":"27","author":"Prigione","year":"2009","journal-title":"Stem Cells"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2174\/1566524011313050016","article-title":"Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation","volume":"13","author":"Stagg","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/mt.2011.189","article-title":"Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation","volume":"20","author":"Francois","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4049\/jimmunol.0902007","article-title":"Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype","volume":"185","author":"Ghannam","year":"2010","journal-title":"J. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12026-014-8612-2","article-title":"Mesenchymal stem cells inhibit Th17 cells differentiation via IFN-\u03b3-mediated SOCS3 activation","volume":"61","author":"Liu","year":"2015","journal-title":"Immunol. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.4049\/jimmunol.0803962","article-title":"Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner","volume":"182","author":"Rafei","year":"2009","journal-title":"J. Immunol."},{"key":"ref_66","first-page":"455","article-title":"Inhibitory effect of human umbilical cord-derived mesenchymal stem cells on interleukin-17 production in peripheral blood T cells from spondyloarthritis patients","volume":"21","author":"Huang","year":"2013","journal-title":"Zhongguo Shi Yan Xue Ye Za Zhi"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.24568","article-title":"Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis","volume":"60","author":"Shen","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3899\/jrheum.110862","article-title":"In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis","volume":"39","author":"Moctezuma","year":"2012","journal-title":"J. Rheumatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/scrt216","article-title":"Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells","volume":"4","author":"Kurte","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.4049\/jimmunol.1401776","article-title":"Conversion of Th17 into IL-17A(neg) regulatory T cells: A novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy","volume":"193","author":"Obermajer","year":"2014","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10875-012-9774-0","article-title":"Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-alpha therapy","volume":"33","author":"Xueyi","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3899\/jrheum.110377","article-title":"Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis","volume":"38","author":"Appel","year":"2011","journal-title":"J. Rheumatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"37559","DOI":"10.1038\/srep37559","article-title":"Functional defects in CD4+ CD25high FoxP3+ regulatory cells in ankylosing spondylitis","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar3257","article-title":"Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+Th\/Treg cell subset imbalance in ankylosing spondylitis","volume":"13","author":"Wu","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","article-title":"Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells","volume":"156","author":"English","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/stem.1432","article-title":"Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes towards anti-inflammatory macrophages","volume":"31","author":"Melief","year":"2013","journal-title":"Stem Cells"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2006-05-024547","article-title":"Immune regulation by pretenders: Cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells","volume":"109","author":"LeMaoult","year":"2007","journal-title":"Blood"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","article-title":"Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells","volume":"26","author":"Selmani","year":"2008","journal-title":"Stem Cells"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: Modulators of CD4+ T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"20044","DOI":"10.1038\/srep20044","article-title":"IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4(+)T-cell responses","volume":"6","author":"Fanelli","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/art.34364","article-title":"Increased numbers of CD5+ B lymphocytes with a regulatory phenotype in spondylarthritis","volume":"64","author":"Cantaert","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Bautista-Caro, M.B., de Miguel, E., Peiteado, D., Plasencia-Rodr\u00edguez, C., Villalba, A., Monjo-Henry, I., Puig-Kr\u00f6ger, A., S\u00e1nchez-Mateos, P., Mart\u00edn-Mola, E., and Miranda-Car\u00fas, M.E. (2017). Increased frequency of circulating CD19+CD24hiCD38hi B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) na\u00efve for biological agents. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180726"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1038\/cddis.2014.147","article-title":"Mesenchymal stem cells infected with Mycoplasma arginini secrete complement C3 to regulate immunoglobulin production in b lymphocytes","volume":"5","author":"Lee","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbrc.2014.04.097","article-title":"Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor","volume":"448","author":"Yan","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/scd.2013.0335","article-title":"Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations","volume":"23","author":"Ungerer","year":"2014","journal-title":"Stem Cells Dev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/scd.2014.0155","article-title":"Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells","volume":"24","author":"Rosado","year":"2015","journal-title":"Stem Cells Dev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1159\/000343340","article-title":"Mesenchymal stem cells support proliferation and terminal differentiation of B cells","volume":"30","author":"Ji","year":"2012","journal-title":"Cell Physiol. Biochem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.lfs.2009.01.013","article-title":"TNF\u03b1 and IL1\u03b2 inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells","volume":"84","author":"Ding","year":"2009","journal-title":"Life Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbrc.2012.12.036","article-title":"Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-\u03b1 in human mesenchymal stem cells","volume":"430","author":"Briolay","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/bdrc.20189","article-title":"Mesenchymal stem cells from development to postnatal joint homeostasis, aging, and disease","volume":"90","author":"Kurth","year":"2010","journal-title":"Birth Defects Res. C. Embryo Today"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Nourissat, G., Diop, A., Maurel, N., Salvat, C., Dumont, S., Pigenet, A., Gosset, M., Houard, X., and Berenbaum, F. (2010). Mesenchymal stem cell therapy regenerates the native bone-tendon junction after surgical repair in a degenerative rat model. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012248"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/jor.21218","article-title":"Mechanical loading increased BMP-2 expression which promoted osteogenic differentiation of tendon-derived stem cells","volume":"29","author":"Rui","year":"2011","journal-title":"J. Orthop. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jcp.25126","article-title":"Ca2+ Signalling in endothelial progenitor cells: Friend or foe?","volume":"231","author":"Moccia","year":"2016","journal-title":"J. Cell Physiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ceca.2015.01.001","article-title":"A novel Ca2+-mediated cross-talk between endoplasmic reticulum and acidic organelles: Implications for NAADP-dependent Ca2+ signaling","volume":"57","author":"Ronco","year":"2015","journal-title":"Cell Calcium"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Kim, T.J., Sun, J., Lu, S., Qi, Y.X., and Wang, Y. (2014). Prolonged mechanical stretch initiates intracellular calcium oscillations in human mesenchymal stem cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109378"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e04876","DOI":"10.7554\/eLife.04876","article-title":"Distinct mechanisms regulating mechanical force-induced Ca2+ signals at the plasma membrane and the ER in human MSCs","volume":"4","author":"Kim","year":"2015","journal-title":"eLife"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/art.39433","article-title":"Imbalance between BMP2 and Noggin induces abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis","volume":"68","author":"Xie","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.2337\/db11-0844","article-title":"Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes","volume":"61","author":"Bassi","year":"2012","journal-title":"Diabetes"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/gutjnl-2012-302152","article-title":"Adipose-derived mesenchymal stromal cells induce mmunomodulatory macrophages which protect from experimental colitis and sepsis","volume":"62","author":"Anderson","year":"2013","journal-title":"Gut"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp. Hematol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/mt.2012.165","article-title":"Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response","volume":"20","author":"Oh","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.4049\/jimmunol.1300667","article-title":"Alveolar macrophages are critical for the inhibition of allergic asthma by mesenchymal stromal cells","volume":"191","author":"Mathias","year":"2013","journal-title":"J. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/leu.2012.202","article-title":"Encapsulated mesenchymal stem cells for in vivo immunomodulation","volume":"27","author":"Zanotti","year":"2013","journal-title":"Leukemia"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.berh.2014.10.023","article-title":"Mesenchymal stromal cells for treatment of arthritis","volume":"28","author":"Swart","year":"2014","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_107","first-page":"117","article-title":"Mesenchymal stem cell therapy for osteoarthritis: Current perspectives","volume":"8","author":"Wyles","year":"2015","journal-title":"Stem Cells Cloning"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/sj.bmt.1703686","article-title":"Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases","volume":"30","author":"Hinterberger","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0301-472X(00)00172-7","article-title":"Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukaemia and severe systemic psoriasis and psoriatic polyarthritis","volume":"28","author":"Slavin","year":"2000","journal-title":"Exp. Hematol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/ard.2005.039479","article-title":"Amelioration of severe psoriasis with psoriatic arthritis for 20 years after allogeneic haematopoietic stem cell transplantation","volume":"65","author":"Woods","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1200\/JCO.2008.17.6560","article-title":"Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma","volume":"26","author":"Braiteh","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/rheumatology\/39.5.563","article-title":"Autologous stem cell transplantation in a lymphoma patient with a long history of ankylosing spondylitis","volume":"39","author":"Jantumen","year":"2000","journal-title":"Rheumatology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1752-1947-6-250","article-title":"Regression of syndesmophyte after bone marrow transplantation for acute myeloid leukemia in a patient with ankylosing spondylitis: A case report","volume":"6","author":"Yang","year":"2012","journal-title":"J. Med. Case Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/bmt.2012.44","article-title":"First autologous hematopoietic SCT for ankylosing spondylitis: A case report and clues to understanding the therapy","volume":"47","author":"Britanova","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3727\/096368913X667727","article-title":"Effects and safety of allogenic mesenchymal stem cells intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: A 20 week clinical trial","volume":"23","author":"Wang","year":"2014","journal-title":"Cell Transplant."},{"key":"ref_116","unstructured":"ClinicalTrials.gov (2017, October 22). Safety and Efficacy Study of Umbilical Cord\/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis, Available online: www.clinicaltrials.gov."},{"key":"ref_117","unstructured":"ClinicalTrials.gov (2017, October 22). A Molecule Basic Study of Early Warning of New Pathogenic Risk of Ankylosing Spondylitis, Available online: www.clinicaltrials.gov."},{"key":"ref_118","unstructured":"ClinicalTrials.gov (2017, October 22). A Pilot Study of MSCs Infusion and Etanercept to Treat Ankylosing Spondylitis, Available online: www.clinicaltrials.gov."},{"key":"ref_119","unstructured":"Chinese Clinical Trial Registry (2017, October 22). Clinical Study of Mesenchymal Stem Cells Transplantation in Ankylosing Spondylitis. Available online: http:\/\/www.chictr.org.cn\/showprojen.aspx?proj=8122."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/1\/80\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:55:48Z","timestamp":1760208948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/1\/80"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,28]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"alternative-id":["ijms19010080"],"URL":"https:\/\/doi.org\/10.3390\/ijms19010080","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,28]]}}}